DBV Technologies (DBVT) Non-Current Debt (2015 - 2020)
DBV Technologies (DBVT) posted Non-Current Debt of $805167.4 for Q2 2020, up 0.89% sequentially from $798066.0 in Q4 2019, and down 28.56% YoY from $1.1 million in Q3 2019.
DBV Technologies (DBVT) Non-Current Debt (2015 - 2020) Analysis & Trends
DBV Technologies has reported Non-Current Debt for 6 years, with the latest figure at $805167.4 in Q2 2020.
- Quarterly Non-Current Debt fell 28.56% year-over-year to $805167.4 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $805167.4 (down 28.56% YoY) and the FY2019 annual result came in at $798066.0, down 45.29% from the prior year.
- Non-Current Debt rose to $805167.4 in Q2 2020 per DBVT's latest filing, from $798066.0 in the prior quarter.
- Over five years, Non-Current Debt peaked at $4.4 million in Q4 2016 and troughed at $798066.0 in Q4 2019.
- A 5-year average of $1.8 million and a median of $1.3 million in 2018 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2016 and 2017: Non-Current Debt decreased 15.01% in 2016, then tumbled 50.85% in 2017.
- Over 5 years, Non-Current Debt stood at $4.4 million in 2016, then sank by 50.85% to $2.1 million in 2017, then sank by 32.12% to $1.5 million in 2018, then tumbled by 45.29% to $798066.0 in 2019, then advanced by 0.89% to $805167.4 in 2020.
- According to Business Quant data, Non-Current Debt over the past three periods registered $805167.4, $798066.0, and $1.1 million for Q2 2020, Q4 2019, and Q2 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 882.16 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 8.96 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | DBV Technologies | 6.08 Bn | 5.90 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 805,167.35 |
| Dec 31, 2019 | 798,066.01 |
| Jun 30, 2019 | 1.13 Mn |
| Dec 31, 2018 | 1.46 Mn |
| Dec 31, 2017 | 2.15 Mn |
| Dec 31, 2016 | 4.37 Mn |
| Dec 31, 2015 | 5.14 Mn |